She is the product of a 39 and 2/7 weeks gestation pregnancy, born to a 29 year-old, G2, P1 now 2 mother, with an estimated date of confinement of [**2174-7-7**].
The infant was born via repeat Cesarean section after mother presented the day of delivery in labor.
No sepsis risk factors were noted and the mother did not receive intrapartum antibiotic prophylaxis.
Anesthesia was combined spinal and epidural with high range of narcotic dose used, due to difficulty with prior delivery.
Maternal obstetric history is notable for prior Cesarean section at term, due to failure to progress but with otherwise uncomplicated pregnancy and neonatal course.
Some of these events required blow-by oxygen and stimulation.
The infant was placed on nasal cannula oxygen due to frequent drifting in oxygen saturations on [**2174-7-11**].
She has remained on nasal cannula at 50 to 75 cc flow and 100% and continues to have occasional events as described above.
on admission to the NICU and IV fluids were initiated.
She was started on enteral feedings on [**2174-7-4**] and allowed to ad lib breast feed again at that time.
The infant did require the initiation of gavage feedings as the enteral feedings were advanced due to poor p.o.
The infant required no phototherapy and the bilirubin level resolved with the most recent bilirubin level of 12.8 over 0.5 on [**2174-7-15**].
Hematology:  No blood typing has been done on this infant.
Antibiotics were not initiated.
A MRI done on [**2174-7-5**] showed a dysgenic brain -        cerebral underdevelopment, underdevelopment of the        anterior operculum, and simplified frontal gyria        (bitemporal perisylvian/ bifrontal polymicrogyria-        pachygyria)    4.
Acetyl carnitine profile on [**2174-7-15**] was normal.
The infant had a 3 day trial of PO Pyridoxine (100mg) which did not change her neurological exam and presentation.
Prior to discharge from the hospital, [**Known lastname 73538**] oxygen and nasogastric tube will be removed.
MEDICATIONS: The infant will be going home on no     medications at this time but medications for comfort     care will be available and have been prescribed by the     PACT Team.
Transdermal gel for seizures of Lorazepam of 0.2              ml or 2 mg.
Lorazepam suppository 0.5 mg p.r.
IMMUNIZATION RECEIVED: The infant has not received any     immunizations thus far.
Visiting nurse [**First Name (Titles) **] [**Last Name (Titles) 2255**] Hospice, telephone number         [**Telephone/Fax (1) 73543**]     c.  Neonatal neurology follow-up with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **],         telephone number [**Telephone/Fax (1) 36468**]     d.  PACT team, Dr. [**Last Name (STitle) 8494**], and nurse practitioner, [**First Name8 (NamePattern2) **]         [**Last Name (NamePattern1) 12424**], telephone number [**Telephone/Fax (1) 47802**] (ask for the         PACT Team)  The parents are aware of the uncertainty regarding life expectancy for [**Known lastname 4489**].
